Datapharm expands into US market through partnership with phactMI

Collaboration aims to enhance accessibility of medicines information

Datapharm has announced its expansion into the United States through a new partnership with phactMI.

The collaboration aims to improve the quality and accessibility of medicines information for healthcare professionals (HCPs) and patients across the US via the phactMI search tool, The Drug Information Database.

Datapharm operates the electronic medicines compendium (emc), a trusted online resource that attracts over 85 million visits globally each year. The emc hosts content from more than 320 global pharmaceutical companies and provides up-to-date information on medicines licensed in the UK.

Meanwhile, phactMI, a collaboration of pharmaceutical companies in the US, is dedicated to transparency in medical information.

“This partnership marks a significant milestone in our mission to support HCPs in delivering informed and effective patient care globally,” said Rich Cooper, CEO of Datapharm. “We are excited to build and strengthen our relationship with phactMI, combining our expertise to offer US HCPs an unmatched medicines information resource.”

Jon Stelzmiller, CEO of phactMI, echoed the sentiment, stating, “phactMI is proud to support this innovative collaboration. Datapharm is uniquely positioned for this role as a specialist tech provider in medicines information.

“By integrating Datapharm’s technology with our platform, we will accelerate our goal of ensuring HCPs have access to comprehensive and accessible medicines information across the United States.”

The agreement between Datapharm and phactMI makes Datapharm’s cutting-edge search technology available to HCPs and patients across the US through phactMI.

This collaboration represents a major step forward in the global dissemination of accurate and accessible medicines information.